SEC Form 4 · accession 0001209191-16-098944
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Travis C Mickle
Officer — President & CEO · Director · 10% Owner
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $12.62 | Feb 11, 2016 | A | 150,000 | A | — | Feb 10, 2026 | Common Stock | 150,000 | 150,000 | D |
| Stock Option (right to buy)F2 | $12.62 | Feb 11, 2016 | A | 20,000 | A | — | Feb 10, 2026 | Common Stock | 20,000 | 20,000 | I |
Explanation of responses
- F1Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 11, 2017 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
- F2Grant to the Reporting Person's spouse of a stock option under the Plan. 25% of the shares will vest on February 11, 2017 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person's spouse is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.